[
{
"old_id":"1",
"old_nametree":"Authors and legal information",
"old_numtree":"1.0.0.0",
"old_htmlpage":"ENAS5268_1.0.0.0",
"new_id":"1",
"new_nametree":"Authors and legal information",
"new_numtree":"1.0.0.0",
"new_htmlpage":"ENAS5268_1.0.0.0"
},
{
"old_id":"2",
"old_nametree":"Prevention of CINV",
"old_numtree":"2.0.0.0",
"old_htmlpage":"null",
"new_id":"2",
"new_nametree":"Prevention of CINV",
"new_numtree":"2.0.0.0",
"new_htmlpage":"null"
},
{
"old_id":"3",
"old_nametree":"Levels of emetogenicity",
"old_numtree":"2.1.0.0",
"old_htmlpage":"ENAS5268_2.1.0.0",
"new_id":"3",
"new_nametree":"Levels of emetogenicity",
"new_numtree":"2.1.0.0",
"new_htmlpage":"ENAS5268_2.1.0.0"
},
{
"old_id":"4",
"old_nametree":"Induced by highly emetogenic ChT",
"old_numtree":"2.2.0.0",
"old_htmlpage":"null",
"new_id":"4",
"new_nametree":"Induced by highly emetogenic ChT",
"new_numtree":"2.2.0.0",
"new_htmlpage":"null"
},
{
"old_id":"5",
"old_nametree":"Overview",
"old_numtree":"2.2.1.0",
"old_htmlpage":"ENAS5268_2.2.1.0",
"new_id":"5",
"new_nametree":"Overview",
"new_numtree":"2.2.1.0",
"new_htmlpage":"ENAS5268_2.2.1.0"
},
{
"old_id":"6",
"old_nametree":"Cisplatin-treated patients",
"old_numtree":"2.2.2.0",
"old_htmlpage":"ENAS5268_2.2.2.0",
"new_id":"6",
"new_nametree":"Cisplatin-treated patients",
"new_numtree":"2.2.2.0",
"new_htmlpage":"ENAS5268_2.2.2.0"
},
{
"old_id":"7",
"old_nametree":"AC-treated female pts. with breast cancer",
"old_numtree":"2.2.3.0",
"old_htmlpage":"ENAS5268_2.2.3.0",
"new_id":"7",
"new_nametree":"AC-treated female pts. with breast cancer",
"new_numtree":"2.2.3.0",
"new_htmlpage":"ENAS5268_2.2.3.0"
},
{
"old_id":"8",
"old_nametree":"Are there differences between the NK1 RAs?",
"old_numtree":"2.2.4.0",
"old_htmlpage":"ENAS5268_2.2.4.0",
"new_id":"8",
"new_nametree":"Are there differences between the NK1 RAs?",
"new_numtree":"2.2.4.0",
"new_htmlpage":"ENAS5268_2.2.4.0"
},
{
"old_id":"9",
"old_nametree":"Other highly emetogenic ChT",
"old_numtree":"2.2.5.0",
"old_htmlpage":"ENAS5268_2.2.5.0",
"new_id":"9",
"new_nametree":"Other highly emetogenic ChT",
"new_numtree":"2.2.5.0",
"new_htmlpage":"ENAS5268_2.2.5.0"
},
{
"old_id":"10",
"old_nametree":"Dose, schedule, route & safety of antieme.",
"old_numtree":"2.3.0.0",
"old_htmlpage":"null",
"new_id":"10",
"new_nametree":"Dose, schedule, route & safety of antieme.",
"new_numtree":"2.3.0.0",
"new_htmlpage":"null"
},
{
"old_id":"11",
"old_nametree":"Overview",
"old_numtree":"2.3.1.0",
"old_htmlpage":"ENAS5268_2.3.1.0",
"new_id":"11",
"new_nametree":"Overview",
"new_numtree":"2.3.1.0",
"new_htmlpage":"ENAS5268_2.3.1.0"
},
{
"old_id":"12",
"old_nametree":"Doses of (5-HT)3 receptor antagonists",
"old_numtree":"2.3.2.0",
"old_htmlpage":"ENAS5268_2.3.2.0",
"new_id":"12",
"new_nametree":"Doses of (5-HT)3 receptor antagonists",
"new_numtree":"2.3.2.0",
"new_htmlpage":"ENAS5268_2.3.2.0"
},
{
"old_id":"13",
"old_nametree":"Doses of corticosteroids",
"old_numtree":"2.3.3.0",
"old_htmlpage":"ENAS5268_2.3.3.0",
"new_id":"13",
"new_nametree":"Doses of corticosteroids",
"new_numtree":"2.3.3.0",
"new_htmlpage":"ENAS5268_2.3.3.0"
},
{
"old_id":"14",
"old_nametree":"Doses of NK1 receptor antagonists",
"old_numtree":"2.3.4.0",
"old_htmlpage":"ENAS5268_2.3.4.0",
"new_id":"14",
"new_nametree":"Doses of NK1 receptor antagonists",
"new_numtree":"2.3.4.0",
"new_htmlpage":"ENAS5268_2.3.4.0"
},
{
"old_id":"15",
"old_nametree":"Olanzapine",
"old_numtree":"2.3.5.0",
"old_htmlpage":"ENAS5268_2.3.5.0",
"new_id":"15",
"new_nametree":"Olanzapine",
"new_numtree":"2.3.5.0",
"new_htmlpage":"ENAS5268_2.3.5.0"
},
{
"old_id":"16",
"old_nametree":"Induced by MEC",
"old_numtree":"2.4.0.0",
"old_htmlpage":"null",
"new_id":"16",
"new_nametree":"Induced by MEC",
"new_numtree":"2.4.0.0",
"new_htmlpage":"null"
},
{
"old_id":"17",
"old_nametree":"Overview",
"old_numtree":"2.4.1.0",
"old_htmlpage":"ENAS5268_2.4.1.0",
"new_id":"17",
"new_nametree":"Overview",
"new_numtree":"2.4.1.0",
"new_htmlpage":"ENAS5268_2.4.1.0"
},
{
"old_id":"18",
"old_nametree":"Carboplatin",
"old_numtree":"2.4.2.0",
"old_htmlpage":"ENAS5268_2.4.2.0",
"new_id":"18",
"new_nametree":"Carboplatin",
"new_numtree":"2.4.2.0",
"new_htmlpage":"ENAS5268_2.4.2.0"
},
{
"old_id":"19",
"old_nametree":"Oxaliplatin",
"old_numtree":"2.4.3.0",
"old_htmlpage":"ENAS5268_2.4.3.0",
"new_id":"19",
"new_nametree":"Oxaliplatin",
"new_numtree":"2.4.3.0",
"new_htmlpage":"ENAS5268_2.4.3.0"
},
{
"old_id":"20",
"old_nametree":"Induced by multiple-day cisplatin ChT",
"old_numtree":"2.5.0.0",
"old_htmlpage":"ENAS5268_2.5.0.0",
"new_id":"20",
"new_nametree":"Induced by multiple-day cisplatin ChT",
"new_numtree":"2.5.0.0",
"new_htmlpage":"ENAS5268_2.5.0.0"
},
{
"old_id":"21",
"old_nametree":"Induced by low & min. emetogenic pot.",
"old_numtree":"2.6.0.0",
"old_htmlpage":"ENAS5268_2.6.0.0",
"new_id":"21",
"new_nametree":"Induced by low & min. emetogenic pot.",
"new_numtree":"2.6.0.0",
"new_htmlpage":"ENAS5268_2.6.0.0"
},
{
"old_id":"22",
"old_nametree":"Breakthr. ChT-induced & refrac. emesis",
"old_numtree":"2.7.0.0",
"old_htmlpage":"ENAS5268_2.7.0.0",
"new_id":"22",
"new_nametree":"Breakthr. ChT-induced & refrac. emesis",
"new_numtree":"2.7.0.0",
"new_htmlpage":"ENAS5268_2.7.0.0"
},
{
"old_id":"23",
"old_nametree":"Prev. of anticipatory nausea and vomiting",
"old_numtree":"2.8.0.0",
"old_htmlpage":"ENAS5268_2.8.0.0",
"new_id":"23",
"new_nametree":"Prev. of anticipatory nausea and vomiting",
"new_numtree":"2.8.0.0",
"new_htmlpage":"ENAS5268_2.8.0.0"
},
{
"old_id":"24",
"old_nametree":"Induced by high-dose chemotherapy",
"old_numtree":"2.9.0.0",
"old_htmlpage":"ENAS5268_2.9.0.0",
"new_id":"24",
"new_nametree":"Induced by high-dose chemotherapy",
"new_numtree":"2.9.0.0",
"new_htmlpage":"ENAS5268_2.9.0.0"
},
{
"old_id":"25",
"old_nametree":"Prevention of RINV",
"old_numtree":"3.0.0.0",
"old_htmlpage":"null",
"new_id":"25",
"new_nametree":"Prevention of RINV",
"new_numtree":"3.0.0.0",
"new_htmlpage":"null"
},
{
"old_id":"26",
"old_nametree":"Overview",
"old_numtree":"3.1.0.0",
"old_htmlpage":"ENAS5268_3.1.0.0",
"new_id":"26",
"new_nametree":"Overview",
"new_numtree":"3.1.0.0",
"new_htmlpage":"ENAS5268_3.1.0.0"
},
{
"old_id":"27",
"old_nametree":"Radiotherapy emetic risk levels",
"old_numtree":"3.2.0.0",
"old_htmlpage":"ENAS5268_3.2.0.0",
"new_id":"27",
"new_nametree":"Radiotherapy emetic risk levels",
"new_numtree":"3.2.0.0",
"new_htmlpage":"ENAS5268_3.2.0.0"
},
{
"old_id":"28",
"old_nametree":"Risk classification",
"old_numtree":"3.3.0.0",
"old_htmlpage":"ENAS5268_3.3.0.0",
"new_id":"28",
"new_nametree":"Risk classification",
"new_numtree":"3.3.0.0",
"new_htmlpage":"ENAS5268_3.3.0.0"
},
{
"old_id":"29",
"old_nametree":"Antiemetic treatment options",
"old_numtree":"3.4.0.0",
"old_htmlpage":"ENAS5268_3.4.0.0",
"new_id":"29",
"new_nametree":"Antiemetic treatment options",
"new_numtree":"3.4.0.0",
"new_htmlpage":"ENAS5268_3.4.0.0"
},
{
"old_id":"30",
"old_nametree":"Concurrent chemoradiotherapy",
"old_numtree":"3.5.0.0",
"old_htmlpage":"ENAS5268_3.5.0.0",
"new_id":"30",
"new_nametree":"Concurrent chemoradiotherapy",
"new_numtree":"3.5.0.0",
"new_htmlpage":"ENAS5268_3.5.0.0"
},
{
"old_id":"31",
"old_nametree":"Acute CINV in children",
"old_numtree":"4.0.0.0",
"old_htmlpage":"ENAS5268_4.0.0.0",
"new_id":"31",
"new_nametree":"Acute CINV in children",
"new_numtree":"4.0.0.0",
"new_htmlpage":"ENAS5268_4.0.0.0"
},
{
"old_id":"32",
"old_nametree":"Antiemetics in advanced cancer",
"old_numtree":"5.0.0.0",
"old_htmlpage":"null",
"new_id":"32",
"new_nametree":"Antiemetics in advanced cancer",
"new_numtree":"5.0.0.0",
"new_htmlpage":"null"
},
{
"old_id":"33",
"old_nametree":"Overview",
"old_numtree":"5.1.0.0",
"old_htmlpage":"ENAS5268_5.1.0.0",
"new_id":"33",
"new_nametree":"Overview",
"new_numtree":"5.1.0.0",
"new_htmlpage":"ENAS5268_5.1.0.0"
},
{
"old_id":"34",
"old_nametree":"NV in malignant bowel obstruction",
"old_numtree":"5.2.0.0",
"old_htmlpage":"ENAS5268_5.2.0.0",
"new_id":"34",
"new_nametree":"NV in malignant bowel obstruction",
"new_numtree":"5.2.0.0",
"new_htmlpage":"ENAS5268_5.2.0.0"
},
{
"old_id":"35",
"old_nametree":"Opioid-induced nausea and vomiting",
"old_numtree":"5.3.0.0",
"old_htmlpage":"ENAS5268_5.3.0.0",
"new_id":"35",
"new_nametree":"Opioid-induced nausea and vomiting",
"new_numtree":"5.3.0.0",
"new_htmlpage":"ENAS5268_5.3.0.0"
},
{
"old_id":"36",
"old_nametree":"Summary of recommendations",
"old_numtree":"6.0.0.0",
"old_htmlpage":"null",
"new_id":"36",
"new_nametree":"Summary of recommendations",
"new_numtree":"6.0.0.0",
"new_htmlpage":"null"
},
{
"old_id":"37",
"old_nametree":"Prevention of CINV",
"old_numtree":"6.1.0.0",
"old_htmlpage":"null",
"new_id":"37",
"new_nametree":"Prevention of CINV",
"new_numtree":"6.1.0.0",
"new_htmlpage":"null"
},
{
"old_id":"38",
"old_nametree":"Levels of emetogenicity",
"old_numtree":"6.1.1.0",
"old_htmlpage":"ENAS5268_6.1.1.0",
"new_id":"38",
"new_nametree":"Levels of emetogenicity",
"new_numtree":"6.1.1.0",
"new_htmlpage":"ENAS5268_6.1.1.0"
},
{
"old_id":"39",
"old_nametree":"Induced by highly emetogenic ChT",
"old_numtree":"6.1.2.0",
"old_htmlpage":"null",
"new_id":"39",
"new_nametree":"Induced by highly emetogenic ChT",
"new_numtree":"6.1.2.0",
"new_htmlpage":"null"
},
{
"old_id":"40",
"old_nametree":"Overview",
"old_numtree":"6.1.2.1",
"old_htmlpage":"ENAS5268_6.1.2.1",
"new_id":"40",
"new_nametree":"Overview",
"new_numtree":"6.1.2.1",
"new_htmlpage":"ENAS5268_6.1.2.1"
},
{
"old_id":"41",
"old_nametree":"Cisplatin-treated patients",
"old_numtree":"6.1.2.2",
"old_htmlpage":"ENAS5268_6.1.2.2",
"new_id":"41",
"new_nametree":"Cisplatin-treated patients",
"new_numtree":"6.1.2.2",
"new_htmlpage":"ENAS5268_6.1.2.2"
},
{
"old_id":"42",
"old_nametree":"AC-treated female pts. with breast cancer",
"old_numtree":"6.1.2.3",
"old_htmlpage":"ENAS5268_6.1.2.3",
"new_id":"42",
"new_nametree":"AC-treated female pts. with breast cancer",
"new_numtree":"6.1.2.3",
"new_htmlpage":"ENAS5268_6.1.2.3"
},
{
"old_id":"43",
"old_nametree":"Other highly emetogenic ChT",
"old_numtree":"6.1.2.4",
"old_htmlpage":"ENAS5268_6.1.2.4",
"new_id":"43",
"new_nametree":"Other highly emetogenic ChT",
"new_numtree":"6.1.2.4",
"new_htmlpage":"ENAS5268_6.1.2.4"
},
{
"old_id":"44",
"old_nametree":"Dose, schedule, route & safety of antiemetics",
"old_numtree":"6.1.3.0",
"old_htmlpage":"null",
"new_id":"44",
"new_nametree":"Dose, schedule, route & safety of antiemetics",
"new_numtree":"6.1.3.0",
"new_htmlpage":"null"
},
{
"old_id":"45",
"old_nametree":"Overview",
"old_numtree":"6.1.3.1",
"old_htmlpage":"ENAS5268_6.1.3.1",
"new_id":"45",
"new_nametree":"Overview",
"new_numtree":"6.1.3.1",
"new_htmlpage":"ENAS5268_6.1.3.1"
},
{
"old_id":"46",
"old_nametree":"Olanzapine",
"old_numtree":"6.1.3.2",
"old_htmlpage":"ENAS5268_6.1.3.2",
"new_id":"46",
"new_nametree":"Olanzapine",
"new_numtree":"6.1.3.2",
"new_htmlpage":"ENAS5268_6.1.3.2"
},
{
"old_id":"47",
"old_nametree":"Induced by MEC",
"old_numtree":"6.1.4.0",
"old_htmlpage":"null",
"new_id":"47",
"new_nametree":"Induced by MEC",
"new_numtree":"6.1.4.0",
"new_htmlpage":"null"
},
{
"old_id":"48",
"old_nametree":"Overview",
"old_numtree":"6.1.4.1",
"old_htmlpage":"ENAS5268_6.1.4.1",
"new_id":"48",
"new_nametree":"Overview",
"new_numtree":"6.1.4.1",
"new_htmlpage":"ENAS5268_6.1.4.1"
},
{
"old_id":"49",
"old_nametree":"Carboplatin",
"old_numtree":"6.1.4.2",
"old_htmlpage":"ENAS5268_6.1.4.2",
"new_id":"49",
"new_nametree":"Carboplatin",
"new_numtree":"6.1.4.2",
"new_htmlpage":"ENAS5268_6.1.4.2"
},
{
"old_id":"50",
"old_nametree":"Oxaliplatin",
"old_numtree":"6.1.4.3",
"old_htmlpage":"ENAS5268_6.1.4.3",
"new_id":"50",
"new_nametree":"Oxaliplatin",
"new_numtree":"6.1.4.3",
"new_htmlpage":"ENAS5268_6.1.4.3"
},
{
"old_id":"51",
"old_nametree":"Induced by multiple-day cisplatin",
"old_numtree":"6.1.5.0",
"old_htmlpage":"ENAS5268_6.1.5.0",
"new_id":"51",
"new_nametree":"Induced by multiple-day cisplatin",
"new_numtree":"6.1.5.0",
"new_htmlpage":"ENAS5268_6.1.5.0"
},
{
"old_id":"52",
"old_nametree":"Induced by low & min. emetogenic pot.",
"old_numtree":"6.1.6.0",
"old_htmlpage":"ENAS5268_6.1.6.0",
"new_id":"52",
"new_nametree":"Induced by low & min. emetogenic pot.",
"new_numtree":"6.1.6.0",
"new_htmlpage":"ENAS5268_6.1.6.0"
},
{
"old_id":"53",
"old_nametree":"Breakthr. ChT-induced & refrac. emesis",
"old_numtree":"6.1.7.0",
"old_htmlpage":"ENAS5268_6.1.7.0",
"new_id":"53",
"new_nametree":"Breakthr. ChT-induced & refrac. emesis",
"new_numtree":"6.1.7.0",
"new_htmlpage":"ENAS5268_6.1.7.0"
},
{
"old_id":"54",
"old_nametree":"Prev. of anticipatory nausea and vomiting",
"old_numtree":"6.1.8.0",
"old_htmlpage":"ENAS5268_6.1.8.0",
"new_id":"54",
"new_nametree":"Prev. of anticipatory nausea and vomiting",
"new_numtree":"6.1.8.0",
"new_htmlpage":"ENAS5268_6.1.8.0"
},
{
"old_id":"55",
"old_nametree":"Induced by high-dose chemotherapy",
"old_numtree":"6.1.9.0",
"old_htmlpage":"ENAS5268_6.1.9.0",
"new_id":"55",
"new_nametree":"Induced by high-dose chemotherapy",
"new_numtree":"6.1.9.0",
"new_htmlpage":"ENAS5268_6.1.9.0"
},
{
"old_id":"56",
"old_nametree":"Prevention of RINV",
"old_numtree":"6.2.0.0",
"old_htmlpage":"null",
"new_id":"56",
"new_nametree":"Prevention of RINV",
"new_numtree":"6.2.0.0",
"new_htmlpage":"null"
},
{
"old_id":"57",
"old_nametree":"Overview",
"old_numtree":"6.2.1.0",
"old_htmlpage":"ENAS5268_6.2.1.0",
"new_id":"57",
"new_nametree":"Overview",
"new_numtree":"6.2.1.0",
"new_htmlpage":"ENAS5268_6.2.1.0"
},
{
"old_id":"58",
"old_nametree":"Risk classification",
"old_numtree":"6.2.2.0",
"old_htmlpage":"ENAS5268_6.2.2.0",
"new_id":"58",
"new_nametree":"Risk classification",
"new_numtree":"6.2.2.0",
"new_htmlpage":"ENAS5268_6.2.2.0"
},
{
"old_id":"59",
"old_nametree":"Antiemetic treatment options",
"old_numtree":"6.2.3.0",
"old_htmlpage":"ENAS5268_6.2.3.0",
"new_id":"59",
"new_nametree":"Antiemetic treatment options",
"new_numtree":"6.2.3.0",
"new_htmlpage":"ENAS5268_6.2.3.0"
},
{
"old_id":"60",
"old_nametree":"Concurrent chemoradiotherapy",
"old_numtree":"6.2.4.0",
"old_htmlpage":"ENAS5268_6.2.4.0",
"new_id":"60",
"new_nametree":"Concurrent chemoradiotherapy",
"new_numtree":"6.2.4.0",
"new_htmlpage":"ENAS5268_6.2.4.0"
},
{
"old_id":"61",
"old_nametree":"Acute CINV in children",
"old_numtree":"6.3.0.0",
"old_htmlpage":"ENAS5268_6.3.0.0",
"new_id":"61",
"new_nametree":"Acute CINV in children",
"new_numtree":"6.3.0.0",
"new_htmlpage":"ENAS5268_6.3.0.0"
},
{
"old_id":"62",
"old_nametree":"Antiemetics in advanced cancer",
"old_numtree":"6.4.0.0",
"old_htmlpage":"null",
"new_id":"62",
"new_nametree":"Antiemetics in advanced cancer",
"new_numtree":"6.4.0.0",
"new_htmlpage":"null"
},
{
"old_id":"63",
"old_nametree":"Overview",
"old_numtree":"6.4.1.0",
"old_htmlpage":"ENAS5268_6.4.1.0",
"new_id":"63",
"new_nametree":"Overview",
"new_numtree":"6.4.1.0",
"new_htmlpage":"ENAS5268_6.4.1.0"
},
{
"old_id":"64",
"old_nametree":"NV in malignant bowel obstruction",
"old_numtree":"6.4.2.0",
"old_htmlpage":"ENAS5268_6.4.2.0",
"new_id":"64",
"new_nametree":"NV in malignant bowel obstruction",
"new_numtree":"6.4.2.0",
"new_htmlpage":"ENAS5268_6.4.2.0"
},
{
"old_id":"65",
"old_nametree":"Opioid-induced nausea and vomiting",
"old_numtree":"6.4.3.0",
"old_htmlpage":"ENAS5268_6.4.3.0",
"new_id":"65",
"new_nametree":"Opioid-induced nausea and vomiting",
"new_numtree":"6.4.3.0",
"new_htmlpage":"ENAS5268_6.4.3.0"
},
{
"old_id":"66",
"old_nametree":"Glossary",
"old_numtree":"7.0.0.0",
"old_htmlpage":"ENAS5268_7.0.0.0",
"new_id":"66",
"new_nametree":"Glossary",
"new_numtree":"7.0.0.0",
"new_htmlpage":"ENAS5268_7.0.0.0"
}
]